Disruption

The Disruptors Bulletin 2021 Q1

07 Jun, 2021

As we move into 2021, coronavirus vaccines have started to be given out, mainly in the richer, developed countries. It will take time for the majority of the population to be vaccinated, perhaps taking a large part of the year, and mostly in developed countries. In the meantime, it may be a difficult first few months in winter due to the rising infections in many countries and new lockdowns may be forthcoming. Nevertheless, despite the rising infections, investors have become more optimistic on the markets in view of the eventual economic recovery when the vaccines work to stop the spread. While the pandemic remains the main focus in 2021, other issues likely to come into view include changes in US economic and geopolitical policies under President Biden, the relationship between US and China and the impact on the rest of the world.



Download Report

 

Disclaimer

You will be leaving this website and will be redirected to a third party website. Please note that the 3rd party site is independent of this website. Lion Global Investors Limited makes no representations, accepts no responsibility for the content, security and privacy policies or the use of the 3rd party site or for that of subsequent links and shall not be liable for any loss or damages caused or alleged to be caused by or in connection with the use of or reliance on any such content, goods or services available on or through the 3rd party site or its subsequent links.

If you do not wish to continue to the 3rd party site, click Close or use the Back button on your web browser.

Disclaimer

You will be leaving this website and will be redirected to a third party website. Please note that the 3rd party site is independent of this website. Lion Global Investors Limited makes no representations, accepts no responsibility for the content, security and privacy policies or the use of the 3rd party site or for that of subsequent links and shall not be liable for any loss or damages caused or alleged to be caused by or in connection with the use of or reliance on any such content, goods or services available on or through the 3rd party site or its subsequent links.

If you do not wish to continue to the 3rd party site, click Close or use the Back button on your web browser.

Comparing the TER cost for 20 years

Here’s the difference a low cost advantage makes to cost savings

Here's how much you pay

$190,272.13
Selected TER 1.00% p.a.

$99,912.57
LionGlobal All Seasons Fund 0.5% p.a.

By investing a fund with low TER

You may save $90,359.56 over 20 years based on an initial investment of $1,000,000 compared with a TER of 0.5% p.a.

It is enough to provide for a monthly expenditure of $3,000 over the next 2 years and 6 months.

Here's how much you pay

$271,950.61
Selected TER 1.50% p.a.

$99,912.57
LionGlobal All Seasons Fund 0.5% p.a.

By investing a fund with low TER

You may save $172,038.04 over 20 years based on an initial investment of $1,000,000 compared with a TER of 0.5% p.a.

It is enough to provide for a monthly expenditure of $3,000 over the next 4 years and 9 months.

Here's how much you pay

$345,744.19
Selected TER 2.00% p.a.

$99,912.57
LionGlobal All Seasons Fund 0.5% p.a.

By investing a fund with low TER

You may save $ 245,831.62 over 20 years based on an initial investment of $1,000,000 compared with a TER of 0.5% p.a.

It is enough to provide for a monthly expenditure of $3,000 over the next 6 years and 9 months.

TER (Total Expense Ratio) is the sum of various identified operating expenses charged on an ongoing basis to the fund’s assets as a percentage of the fund’s average net asset value calculated over a 12-month period at the close of the annual and semi-annual financial statements of the fund for all the p.a. tabs (1.0%, 1.5%, 2.0%).

The above scenarios are for illustration purpose only. Past performance, as well as any prediction, projection or forecast on the economy, securities market or the economic trends of the markets are not necessarily indicative of the future or likely performance of the funds. Calculations based purely on costs with no market movement or investment returns.